Steven H. Bloom insider trades
Open-market stock purchases and sales by Steven H. Bloom, Chief Business Officer at Werewolf Therapeutics, Inc, from SEC Form 4 filings since Jan 5, 2018.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -39%.
Recent trades
No open-market trades in the last 12 months.